Navigation Links
Rising Rates Of C.Difficile Infection Among Non-Hospitalized Patients

Report of the rising rates of infection with C.difficile among the general public has led to concerns regarding the mutation of the microorganism into a more virulent form.// It was previously thought that the infection could only manifest in individuals with resistance to antibiotics.

The high incidence of the infection even among non-hospitalized patients has created much panic among the scientific community. "That is really a remarkably high increase in cases. "I think this needs verification in another database, to tell you the truth. And it may be that it's true. And it may be that there's something going on, " said Dr. Dale Gerding, a leading U.S. expert in the field.

The researchers examined a large database for identification of C. difficile infected cases in Britain. Surprisingly, the individuals identified did not have a positive history of hospital admission the previous year. The results of the present study have been presented in the Journal of the American Medical Association.

Infection with the microorganism is most commonly hospital acquired with a majority of the cases occurring within health-care facilities. High rates of antibiotic usage and the difficulty to eradicate the sporocytic form of C. difficile are some of the factors believed to account for the high rates of infection in hospitals.

The consumption of antibiotics destroys the natural bacterial flora present in the intestine, and enhances the susceptibility to the infection. C.difficile now happily grows and thrives in an otherwise hostile environment leading to symptoms such as severe diarrhea, abdominal pain, and fever.

An alarming rate of the infection incidence in Britain from 1 to 22 cases per 100, 000 has been found during the 10-year period (1994- 2004). Out of this, only 37% of the infected individuals had taken antibiotics prior to the infection episode.

In addition it was found that those taking Nexium (pro ton pump inhibitors, powerful antacid drugs) were three times more likely to contract the infection. Accidentally, it was found that patients on non-steroidal anti-inflammatory drugs (NSAIDs) also had an elevated risk.

The new potent strain of the bacterium is known for production of massive levels of toxic substances compared to the traditional ones. It has been held responsible for deadly outbreaks that have plagued hospitals in parts of Quebec over the few years. Appropriate techniques have to be taken to identify genetic changes within such potent forms even before permutation can occur.


'"/>




Related medicine news :

1. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
2. Rising Rates of Whooping Cough in Idaho
3. Breast Cancer In India Rising Rapidly
4. Rising Medicare costs
5. Rising in career top charts is Medical transcription
6. Rising Number of Preterm Births Cause Concern
7. Rising Rates of Obesity and Diabetes Puts Pressure on the Australians
8. UN Sounds Alarm Over Rising Cocaine Consumption In Europe
9. Government Failed to Prevent Rising Teen Pregnancies
10. Drug Prices Rising Faster Than Inflation
11. Rising numbers indicate looming cocaine epidemic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: